Please ensure Javascript is enabled for purposes of website accessibility U.S. Financial Professionals | Janus Henderson Investors

Active and passive investing – all in the blend

Janus Henderson Co-CEO Dick Weil talks to Bloomberg TV about the benefits of combining an active and passive approach to investing. He also provides his view on the risk of crowded trades, the scope for interest rate rises, and taking advantage of growth in the Chinese market.

Dispelling the myths of sustainable investment

Positive impact stocks Global Sustainable Equity

In this video presentation, Hamish Chamberlayne, Portfolio Manager within Janus Henderson’s Global Sustainable and Responsible Investment Team, dispels the major myths about sustainable investment. He explains how environmental and social megatrends will accelerate the transition to a low carbon economy and discusses some of the investment areas that stand to be disrupted.

Quick view: Amazon takes on healthcare

Global Life Sciences: our approach to seeking innovators in cancer therapy | Janus Henderson Investors

Rich Carney, Healthcare Services Analyst with the US-based Janus Henderson Healthcare Sector Team, responds to news that Amazon, Berkshire Hathaway, and JPMorgan Chase plan to form an independent healthcare company to lower costs for their employees.

Inflation — the dog that never barks

John Pattullo | Janus Henderson Investors

​The biggest surprise last year was not only the persistent mis-forecasting of bond yields but also the persistent mis-forecasting of inflation. John Pattullo, Co-Head of Strategic Fixed Income, looks at the underlying causes of why a lot of traditional economic models, assumptions and relationships do not seem to hold in this rather dystopian world in which we live.

Quick view: healthcare – Amazon’s next target?

Test tubes | Navigating the drug pricing debate | Janus henderson Investors

Alison Porter, Graeme Clark, and Richard Clode, Portfolio Managers within the Janus Henderson Global Technology Team, provide their views on the news that Amazon, JP Morgan and Berkshire Hathaway are forming an alliance with the aim of lowering healthcare costs for the companies’ employees.

Quick view: healthcare – Amazon’s next disruption target?

Test tubes | Navigating the drug pricing debate | Janus henderson Investors

Alison Porter, Graeme Clark, and Richard Clode, Portfolio Managers within the Janus Henderson Global Technology Team, provide their views on the news that Amazon, JP Morgan and Berkshire Hathaway are forming an alliance with the aim of lowering healthcare costs for the companies’ employees.

Quick view: Amazon takes on healthcare

Global Life Sciences: our approach to seeking innovators in cancer therapy | Janus Henderson Investors

Rich Carney, Healthcare Services Analyst with the US-based Janus Henderson Healthcare Sector Team, responds to news that Amazon, Berkshire Hathaway, and JPMorgan Chase plan to form an independent healthcare company to lower costs for their employees. Rich is also a member of the investment team for the Janus Henderson Global Life Sciences strategy.

Essentials: Global Life Sciences Strategy

In this Essentials video for the Janus Henderson Global Life Sciences Strategy, meet co-managers Andy Acker and Ethan Lovell. Learn about their approach to investing, and what differentiates their strategy from others in the healthcare peer group.

Essentials: the Total Return Bond strategy

In this ‘Essentials’ video, Phillip Apel and Andrew Mulliner, portfolio managers within the Fixed Income Investment Strategy Group (ISG), outline the key features of the Total Return Bond strategy, including its ‘strength in depth’ team approach and its unconstrained global remit.